Blood Pressure News and Research

RSS

Blood Pressure is the force of circulating blood on the walls of the arteries. Blood pressure is taken using two measurements: systolic (measured when the heart beats, when blood pressure is at its highest) and diastolic (measured between heart beats, when blood pressure is at its lowest). Blood pressure is written with the systolic blood pressure first, followed by the diastolic blood pressure (for example 120/80).

Deaths from cardiovascular disease higher in winter and lower in summer, says doctor

Dr Marques-Vidal said: "Deaths from cardiovascular disease are higher in winter and lower in summer. We decided to conduct a large scale study to see whether cardiovascular risk factors have a seasonal pattern which could explain the seasonality in deaths."

2 Sep 2013

Life expectancy gap growing between older women in rich and poor countries: Study

Measures taken in developed countries to reduce noncommunicable diseases - the leading causes of death globally - have improved the life expectancy of women aged 50 years and older over the last 20 to 30 years.

2 Sep 2013

'Quest to Cure MSA in Honor of Rex Griswold' drives in-depth genomic investigation of rare nerve disorder

Rex Griswold, Vice President of Sales for Nestl- Waters North America, was a driving force at the company for more than two decades until Multiple System Atrophy (MSA) suddenly struck him.

31 Aug 2013

European Commission approves Stivarga tablets for treatment of patients with mCRC

Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced today that the European Commission has approved Stivarga® (regorafenib) tablets for the treatment of adult patients with metastatic colorectal cancer (mCRC).

30 Aug 2013

BP and headache drug effectively speeds up treatment of TB

Infectious disease experts at Johns Hopkins have found, in studies in mice, that a drug better known as a treatment for high blood pressure and headaches effectively speeds up treatment of TB when added to the standard, daily antibiotic regimen. Test animals were cured in four months instead of the usual six.

30 Aug 2013

Engaging in physical activity not going to put at greater risk of knee osteoarthritis

Adults age 45 and older who engaged in moderate physical activity up to two and a half hours a week did not increase their risk of developing knee osteoarthritis over a 6-year follow-up period, a new study finds.

29 Aug 2013

Study to test ability of doxycycline dose to reduce growth of abdominal aortic aneurysms

A new clinical study at the University of Michigan Health System will test the ability of a once daily dose of doxycycline to reduce the growth of small abdominal aortic aneurysms.

29 Aug 2013

Ingestion of strong opioids can cause central nervous system depression, death in young children

Medication poisonings among children are an important public health problem. During 2010-2011, an average of 1500 children under 6 years of age was evaluated in emergency departments each year due to unintentional exposure to buprenorphine. Ingestion of strong opioids, such as buprenorphine, can cause central nervous system depression, respiratory depression, and death in young children.

29 Aug 2013

Pulmonary hypertension may be caused by molecular pathway that damages blood vessels

Pulmonary hypertension, a deadly form of high blood pressure that develops in the lungs, may be caused by an inflammation-producing molecular pathway that damages the inner lining of blood vessels, according to a new study by researchers at the Stanford University School of Medicine.

29 Aug 2013

FDA grants Priority Review designation to sNDA for Nexavar tablets

Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.

27 Aug 2013

Weight-management intervention effective for weight gain prevention among black women

An intervention not focused on weight loss was effective for weight gain prevention among socioeconomically disadvantaged black women, according to a report published by JAMA Internal Medicine, a JAMA Network publication.

27 Aug 2013

Examining cost: Why are health care services so expensive?

The New York Times looks at the cost of care and asks why it's so difficult for consumers to find out what a service costs. In the meantime, new research shows ending copays and making medication easier to use drives lower rates of hypertension.

27 Aug 2013

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.

27 Aug 2013

Research roundup: Moving kids onto Medicaid; competitive markets

Each week, KHN compiles a selection of recently released health policy studies and briefs.

26 Aug 2013

Structured exercise can improve heart function in patients with kidney disease

A structured exercise and lifestyle program can improve fitness, body composition, and heart function in patients with kidney disease, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

23 Aug 2013

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.

22 Aug 2013

Assumption that uterine blood redistributed into maternal circulation after delivery challenged

In an examination comparing the effects of two drugs on blood pressure, pulse, heart rate and cardiac output in women having elective delivery by cesarean section, an old assumption that uterine blood is redistributed into the maternal circulation after delivery was challenged, according to a study in the September issue of Anesthesiology.

22 Aug 2013

Hypertension researcher receives Distinguished Scientist title from AHA

Kenneth Bernstein, MD, a Cedars-Sinai pathologist and scientific researcher known for expanding the understanding of a collection of proteins important in controlling blood pressure as well as heart and renal diseases, has been named a 2013 Distinguished Scientist by the American Heart Association.

21 Aug 2013

Implementation of large-scale hypertension program linked with doubling of hypertension control rates

Implementation of a large-scale hypertension program that included evidence-based guidelines and development and sharing of performance metrics was associated with a near-doubling of hypertension control between 2001 and 2009, compared to only modest improvements in state and national control rates, according to a study in the August 21 issue of JAMA.

21 Aug 2013

Noninvasive measure of oxygen levels in leg muscles improves outcomes in peripheral arterial disease patients

For millions of Americans, simply walking to the mailbox can cause unbearable leg pain as muscles scream for more blood and oxygen.

21 Aug 2013

Blood Pressure News and Research

Further Reading

Deaths from cardiovascular disease higher in winter and lower in summer, says doctor

Life expectancy gap growing between older women in rich and poor countries: Study

'Quest to Cure MSA in Honor of Rex Griswold' drives in-depth genomic investigation of rare nerve disorder

European Commission approves Stivarga tablets for treatment of patients with mCRC

BP and headache drug effectively speeds up treatment of TB

Engaging in physical activity not going to put at greater risk of knee osteoarthritis

Study to test ability of doxycycline dose to reduce growth of abdominal aortic aneurysms

Ingestion of strong opioids can cause central nervous system depression, death in young children

Pulmonary hypertension may be caused by molecular pathway that damages blood vessels

FDA grants Priority Review designation to sNDA for Nexavar tablets

Weight-management intervention effective for weight gain prevention among black women

Examining cost: Why are health care services so expensive?

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Research roundup: Moving kids onto Medicaid; competitive markets

Structured exercise can improve heart function in patients with kidney disease

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Assumption that uterine blood redistributed into maternal circulation after delivery challenged

Hypertension researcher receives Distinguished Scientist title from AHA

Implementation of large-scale hypertension program linked with doubling of hypertension control rates

Noninvasive measure of oxygen levels in leg muscles improves outcomes in peripheral arterial disease patients

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News